Presentation is loading. Please wait.

Presentation is loading. Please wait.

Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients  Patrizia Weber, MD, S. Morteza Seyed Jafari,

Similar presentations


Presentation on theme: "Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients  Patrizia Weber, MD, S. Morteza Seyed Jafari,"— Presentation transcript:

1 Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients  Patrizia Weber, MD, S. Morteza Seyed Jafari, MD, Nikhil Yawalkar, MD, Robert E. Hunger, MD, PhD  Journal of the American Academy of Dermatology  Volume 76, Issue 6, Pages (June 2017) DOI: /j.jaad Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Response to apremilast in patient 2 with gluteal hidradenitis suppurativa. A, Before therapy, erythema, edema, confluent nodules, multiple fistulae, and comedones are present. During therapy, a reduction in erythema, edema, and nodules was observed, though comedones, scars, and hyperpigmentation remained. B, After 2 months of therapy. C, After 8 months of therapy. D, After 9 months of therapy. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions


Download ppt "Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients  Patrizia Weber, MD, S. Morteza Seyed Jafari,"

Similar presentations


Ads by Google